Related Experiment Video
Updated: Aug 18, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
[Prevalence of hepatitis C virus antibody in chronic HBsAg-negative non alcoholic hepatopathy]
R Bárcena Marugán1, R Nash, J M Pascasio
1Servicio de Gastroenterología y de Microbiología del Hospital Ramón y Cajal, Facultad de Medicina, Universidad de Alcalá.
Insights
Antibody to hepatitis C virus (HCV) was found in 76.6% of patients with non-alcoholic chronic hepatitis. Blood transfusion recipients showed a higher prevalence of anti-HCV, suggesting HCV
Area of Science:
- Hepatology
- Virology
- Immunology
Context:
- Non-alcoholic chronic hepatitis represents a significant clinical challenge.
- Distinguishing between different viral etiologies is crucial for patient management.
- Hepatitis C virus (HCV) infection is a major cause of chronic liver disease.
Purpose:
- To determine the prevalence of antibody to hepatitis C virus (anti-HCV) in patients with non-alcoholic chronic hepatitis.
- To investigate potential risk factors associated with anti-HCV positivity in this cohort.
- To assess the role of HCV in non-alcoholic chronic hepatitis cases.
Summary:
- Antibody to hepatitis C virus (anti-HCV) was detected in 76.6% of 316 HBsAg-negative patients with non-alcoholic chronic hepatitis.
- A higher prevalence of anti-HCV was observed in patients with a history of blood transfusion (87.4%) compared to other risk groups.
- The incidence of anti-HCV was lower in cirrhotics (70.3%) than in active chronic hepatitis (84.1%), with a higher transfusion history in the latter group.
Impact:
- These findings suggest that hepatitis C virus infection is a significant contributor to non-alcoholic chronic hepatitis.
- Highlights the importance of screening for anti-HCV in patients with chronic hepatitis of unknown etiology.
- Informs clinical practice regarding the etiological diagnosis and management of chronic liver disease.
Abstract:
The presence of antibody to hepatitis C virus was determined in 316 HBsAg-negative patients with non-alcoholic chronic hepatitis who did not receive any blood transfusion once the diagnosis was made. A titre of antinuclear antibodies of 1/40 or lower was found in 18 patients. Persistent chronic hepatitis was present in 21 patients, active chronic hepatitis in 145, hepatic cirrhosis in 128, and hepatocarcinoma in 22 patients. One hundred and three patients had previously received blood transfusion, 76 had undergone previous surgery without transfusion, a clinical episode of hepatitis could be traced in 14, 13 patients were drug addicts (all of them HIV negative), 1 patient had received multiples injections, another had been treated with acupuncture, and 108 patients were free of any of the above. Anti-HCV was present in 76.6% of patients; a significantly higher proportion (87.4%) was found among patients who had received blood transfusion than in patients with previous surgery (72.4%) (p = 0.012), clinical hepatitis (57.1%), or without previous hepatic disease (70.3%) (p = 0.003). The incidence of anti-HCV was lower among cirrhotics (70.3%) than in patients with active chronic hepatitis (84.1%) (p = 0.006); in contrast, previous blood transfusion was significantly higher (p = 0.001) among the latter (40.7%) than in cirrhotics (21.9%). The incidence of anti-HCV was similar among patients with (78.6%) and without (75.8%) type B infection. Our results suggest that infection with virus C may account for a high proportion of non-alcoholic non-B chronic hepatitis.
Related Concept Videos
Cytomegalovirus Disease
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis I: Introduction

